Disopyramide—An Effective Treatment for Lignocaine Resistant Ventricular Dysrhythmias
- 1 January 1979
- journal article
- research article
- Published by SAGE Publications in Scottish Medical Journal
- Vol. 24 (1) , 21-24
- https://doi.org/10.1177/003693307902400106
Abstract
Intravenous disopyramide was used in 13 patients who developed recurrent ventricular dysrhythmias despite initial treatment with intravenous lignocaine after admission to the Coronary Care Unit of a busy district hospital. This was effective in 8 of the 13 patients treated and there was no major side effects observed. Disopyramide has the advantage of being available both as an oral and an intravenous preparation and is a useful drug to be added to the list of more conventional anti-dysrhythmic agents.This publication has 17 references indexed in Scilit:
- Lidocaine in the Prevention of Primary Ventricular FibrillationNew England Journal of Medicine, 1974
- Editorial: Adverse reactions to beta-adrenergic blockade.BMJ, 1974
- TRIAL OF COMBINED INTRAMUSCULAR AND INTRAVENOUS LIGNOCAINE IN PROPHYLAXIS OF VENTRICULAR TACHYARRHYTHMIASThe Lancet, 1972
- Lignocaine Therapy for Ventricular Ectopic Activity after Acute Myocardial Infarction: A Double-blind TrialBMJ, 1971
- LIGNOCAINE IN THE MANAGEMENT OF ARRHYTHMIAS AFTER ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1968
- Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart DiseaseNew England Journal of Medicine, 1967
- The Coronary Care UnitJAMA, 1967
- Mortality Reduction in a Coronary Care UnitBMJ, 1966
- Disturbances of rate, rhythm and conduction in acute myocardial infarctionThe American Journal of Medicine, 1964
- CORONARY UNIT AN INTENSIVE-CARE CENTRE FOR ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1963